Nanotechnology in Cardiology: A New Era of Targeted Therapies and Advanced Diagnostics-A Review

Area of Science:

• Cardiovascular Medicine
• Nanotechnology
• Biomedical Engineering

Background:

• Cardiovascular diseases (CVDs) remain the leading global cause of mortality, causing approximately 33% of deaths in 2021.
• Current therapeutic strategies face challenges including systemic toxicity, non-specific drug distribution, and invasive procedures.
• Existing medical advancements have not fully overcome these therapeutic limitations.

Purpose of the Study:

• To examine the current developments in nanomedicine for cardiovascular disease (CVD) diagnostics and therapy.
• To demonstrate the potential of nanomedicine to revolutionize precise cardiology.
• To highlight the application of nanotechnology in minimally invasive diagnostics and integrated therapeutic systems.

Main Methods:

• Review of current nanomedicine advancements in cardiovascular applications.
• Analysis of nanoparticle-based systems (polymeric nanoparticles, liposomes, dendrimers, solid lipid nanoparticles) for drug delivery and release.
• Exploration of novel nanomaterials (gold nanoparticles, carbon nanotubes, graphene derivatives) in molecular imaging and regenerative cardiology.

Main Results:

• Nanotechnology enhances therapeutic efficacy and reduces side effects through targeted drug delivery and controlled release.
• Nanoparticle-based systems improve visualization precision in diagnostic imaging.
• Novel nanomaterials are advancing molecular imaging and regenerative cardiology techniques.

Conclusions:

• Nanomedicine provides effective solutions to overcome limitations in current CVD treatments.
• Nanotechnology facilitates precise cardiology through targeted therapies and minimally invasive diagnostic methods.
• The integration of nanomedicine promises a future of advanced, personalized cardiovascular care.